site stats

Eli lilly pe ratio

WebApr 12, 2024 · The company has a market capitalization of $345.95 billion, a PE ratio of 52.76, a P/E/G ratio of 2.09 and a beta of 0.36. Eli Lilly and has a 1 year low of $276.83 and a 1 year high of $384.44. WebMar 25, 2024 · LLY PE Ratio (Forward) data by YCharts Note as well that the average forward price-to-earnings (P/E) ratio for the industry is 11.7, while for the S&P 500 it stands at 18.2. Eli Lilly's...

Eli Lilly (LLY) Pe Ratio (TTM) - Zacks.com

Web56 rows · The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Eli Lilly PE ratio as of March 31, 2024 is 43.25. Please refer to the Stock Price Adjustment Guide for more information on our … Pfizer (Pfe) - Eli Lilly PE Ratio 2010-2024 LLY MacroTrends Current and historical p/e ratio for Johnson & Johnson (JNJ) from 2010 to 2024. … The current P/S ratio for Eli Lilly as of February 01, 2024 is . For more … Eli Lilly annual/quarterly revenue history and growth rate from 2010 to 2024. … Historical daily share price chart and data for Eli Lilly since 1972 adjusted for splits. … AbbVie (Abbv) - Eli Lilly PE Ratio 2010-2024 LLY MacroTrends Novartis AG (Nvs) - Eli Lilly PE Ratio 2010-2024 LLY MacroTrends WebApr 12, 2024 · The stock’s fifty day moving average is $334.40 and its 200 day moving average is $346.30. Eli Lilly and Company has a fifty-two week low of $276.83 and a fifty-two week high of $384.44. The firm has a market capitalization of $345.95 billion, a PE ratio of 52.76, a PEG ratio of 2.09 and a beta of 0.36. e and o insurance for signing agents https://thecoolfacemask.com

LLY (Eli Lilly and Co) Shiller PE Ratio - GuruFocus

WebThe PEG ratio for this company is based on expected earnings for twelve months ending July 2024 Back to LLY Overview Data Provider: Data is provided by Zacks … WebEli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Ownership Insider Ownership Percentage Upgrade WebApr 6, 2024 · The p/e ratio for Eli Lilly and Co (LLY) stock today is 53.30. It's worsened by 7.79% from its 12-month average of 49.45. LLY's forward pe ratio is 39.06. The p/e ratio … csr basecoat 60

Eli Lilly and Company (NYSE:LLY) Stock Valuation - Simply Wall St

Category:PE RATIO.docx - When selecting comparable companies to...

Tags:Eli lilly pe ratio

Eli lilly pe ratio

Now May Be A Good Time To Consider Selling Eli Lilly Stock - SeekingAlpha

WebApr 11, 2024 · About PE Ratio (TTM) Eli Lilly and Company has a trailing-twelve-months P/E of 46.22X compared to the Large Cap Pharmaceuticals industry's P/E of 15.06X. … WebEli Lilly annual free cash flow for 2024 was $5.23B, a 12.11% decline from 2024. Eli Lilly annual free cash flow for 2024 was $5.951B, a 16.42% increase from 2024. Eli Lilly annual free cash flow for 2024 was $5.112B, a 34.42% increase from 2024. Compare LLY With Other Stocks From: To: Zoom: 1,000 2,000 3,000 4,000 5,000 6,000 Annual Values

Eli lilly pe ratio

Did you know?

WebYear Ending Dec 2024 (Update) Year Ending Dec 2024 (Update) Year Ending Dec 2016 (Update) Year Ending Dec 2015 (Reclassified) Year Ending Dec 2014 (Reclassified) Year Ending Dec 2013 (Update) Net Income/Starting Line. 6.24M. 5.58M. WebDec 27, 2024 · Eli Lilly and Company (NYSE:LLY) is currently trading at a trailing P/E of 40.3x, which is higher than the industry average of 23.9x. ... Price-Earnings Ratio = Price per share ÷ Earnings per ...

WebJan 31, 2024 · Eli Lilly is a strong pharma company with an exciting pipeline, but the market ran away with its valuation. ... looking at the forward PE ratio of ~29x, Lilly stock looks unattractive compared to ... WebP/E ratio as of April 2024 (TTM): 61.4 According to Eli Lilly 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 61.3817 . At the end …

WebThis ratio is calculated by dividing the current Price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes for the latest annual … WebDec 23, 2024 · The price/earnings-to-growth (PEG) ratio is a company's stock price to earnings ratio divided by the growth rate of its earnings for a specified time period. more. Price-to-Book (PB) Ratio ...

WebApr 7, 2024 · Eli Lilly and Company's PEG ratio. Eli Lilly and Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.1814. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

WebGet the latest Eli Lilly and Company (LLY) stock news and headlines to help you in your trading and investing decisions. Home; ... PE Ratio (TTM) 53.54: EPS (TTM) N/A: Earnings Date: N/A: e and o insurance for life producersWebApr 7, 2024 · Currently, Eli Lilly And Co’s price-earnings ratio is 48.6. Eli Lilly And Co’s trailing 12-month revenue is $28.5 billion with a 21.9% net profit margin. Year-over-year quarterly sales growth most recently was -8.7%. Analysts expect adjusted earnings to reach $8.503 per share for the current fiscal year. eandoverWebEli Lilly and Co (NYSE:LLY) PE Ratio Explanation The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. … csrb building umich